References
- Division of STD/HIV prevention annual report. Atlanta: Centers for Disease Control, 1989
- Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA 1991: 266(18): 2565–9
- Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease: what are the questions? JAMA 1991: 266(18): 2587–93
- Eschenbach DA. Bacterial vaginosis: emphasis on upper genital tract complications. Obstet Gynecol Clin North Am 1989: 16(3): 593–610
- Soper DE, Brockwell NJ, Dalton HP. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol 1992: 167(3): 653–60
- Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol Rev 1990: 12: 199–220
- Sweet RL, Gibbs RS. Infectious diseases of the female genital tract. 2d ed. Baltimore: Williams & Wilkins, 1990: 241–66
- Miettinen A, Saikku P, Jansson E, et al. Epidemiologic and clinical characteristics of pelvic inflammatory disease associated with Mycoplasma hominis, Chlamydia trachomatis, and Neisseria gonorrhoeae. Sex Transm Dis 1986: 13(1): 24–8
- Washington AE, Aral SO, Wølner-Hanssen P, et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991: 266(18): 2581–6
- Kessel E. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertil Steril 1989: 51 (1): 1–11
- Hager WD, Eschenbach DA, Spence MR, et al. Criteria for diagnosis and grading of salpingitis. (Editorial) Obstet Gynecol 1983: 61(1): 113–4
- Eschenbach DA. Acute pelvic inflammatory disease. Urol Clin North Am 1984: 11(1): 65–81
- Centers for Disease Control. 1989 sexually transmitted diseases treatment guidelines. MMWR 1989: 38(S-8): 31–3
- Peterson HB, Galaid EI, Cates W Jr. Pelvic inflammatory disease. Med Clin North Am 1990: 74(6): 1603–15
- Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991: 266(18): 2574–80